The phrase "ability to detect small" is correct and usable in written English.
It can be used when discussing someone's or something's capacity to notice or identify small details or objects.
Example: "The scientist's ability to detect small changes in temperature was crucial for the experiment's success."
Alternatives: "capacity to notice minor" or "skill in identifying tiny".
He invented the electron capture detector, which has greatly enhanced our ability to detect small quantities of pollutants, and was critical to the detection of chlorofluorocarbons in the atmosphere and the attribution of their responsibility for ozone depletion.
One of the main advantages of CMA over chromosome analysis is its ability to detect small CNVs, enabling discovery of mosaicism for abnormalities not previously detectable.
The local approach has ability to detect small changes very effectively.
Developments towards higher resolution and the ability to detect small defects are bringing a step-change in non-destructive testing.
He said his order would prohibit further public discussion of the system's false-alarm rates, its ability to detect small amounts of explosives and operating methods.
An extensive analytic model has been developed that shows an ability to detect small tumors, a few centimeters deep inside the tissue.
FBAR outperformed FASTER on all test data, due mainly to its ability to detect small artifacts in the presence of high amplitude EEG.
The ability to detect small amounts of materials, including biological entities such as pathogenic bacteria, is important for medical diagnostics, detection of infectious agents, mass based flow cytometry, and sizing of colloidal particles.
In the first study we found that the two tools and the pisiform grip provided equivalent ability to detect small differences in elastic stiffness, however the tools introduced a bias so that the stiffness stimuli felt stiffer than when assessed with the pisiform grip.
In an effort to improve the ability to detect small volume disease, we have evaluated the usefulness of N -acetylglucosamine:β1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer.
The sample size of 40 patients limits our ability to detect small differences in the sensitivity of the two radiopharmaceuticals.
